CME Multiple-Choice Questions

CME Multiple-Choice Questions

Continuing Medical Education CME Multiple-Choice Questions jsm_2109 1. Use of phosphodiesterase type 5 inhibitors (PDE5i’s) in men with spinal cord ...

115KB Sizes 7 Downloads 134 Views

Continuing Medical Education CME Multiple-Choice Questions

jsm_2109

1. Use of phosphodiesterase type 5 inhibitors (PDE5i’s) in men with spinal cord injury is often unsafe, owing to hypotensive effects of these vasodilators. a. True. Symptomatic hypotension is the most common side effect experienced among men with spinal cord injuries exposed to PDE5i’s; b. True. However, if men have supine blood pressures taken and demonstrate systolic pressures greater than 120 mm Hg, little concern is needed; c. False. The incidence of clinically significant blood pressure changes among the spinal cord-injured population is almost equivalent to the general population; d. Unclear at present. More studies are needed before a definitive statement can be made. 2. Among men with spinal cord injury and erectile dysfunction (ED), use of PDE5i’s are a. marginally effective when testosterone is measured in the normal range; b. rarely effective as the required nitric oxide pathways are functionally absent; c. as effective as those men with ED secondary to radical prostatectomy; d. generally about 80% successful in achieving and maintaining erectile rigidity. 3. Use of surgical implants for ED in men with spinal cord injury is: a. often a good first choice as medical management and injection therapy are frought with hand function issues and other complications;

J Sex Med 2010;7:3815–3816

3815..3816

b. a good option among men with high cervical cord injuries as injection therapy is difficult to manipulate; c. a reasonable choice in cases where less invasive options have failed, once the patient understands that erosion and infection may be more common than among neurologically intact individuals; d. generally contraindicated as it is a high-risk, low-reward approach to treating ED in this population. 4. Use of Intracavernous Vasoactive Injection therapy for men with spinal cord injuries and ED is: a. a reasonable and effective option when firstline treatments fail or cost of other options is prohibitive; b. rarely successful, owing to impaired manual dexterity; c. often limited by recurrent episodes of priapism and infections; d. is very challenging to teach to the nonneurologically intact individual or partner. 5. Among men with spinal cord injuries, use of Vacuum Constriction Devices for ED is: a. often less effective because the constriction ring causes pain; b. risky, as a result of reduced sensation and greater likelihood of incomplete constriction ring causing veno-occlusion; c. not often successful as manual dexterity and efficacy often limit utility; d. a reasonable first-line agent, particularly in high C-spine injuries.

3815

Continuing Medical Education

Overall evaluation of the activity a. Excellent b. Very good c. Good d. Fair e. Poor

What degree of confidence do you have that you will apply your new learning in your practice? 100% 75% 50% 25% 0%

Was this activity responsive to your needs? Yes No

What one change will you make in your practice based on this new learning?

Was this activity relevant to your practice? Yes No

This activity is designed for a maximum of 1 category 1 credit. You should only claim the number of credits you have earned based on the amount of time needed to complete this activity. How many credits are you claiming for this activity? a. 1 b. 0.75 c. 0.5 d. 0.25

Did this activity increase your knowledge and/or skills in delivering patient care? Yes No

List any topics you would find interesting and professionally relevant for future CME activities:

Please indicate your current profession: 䊐 Physician 䊐 Nurse 䊐 Physician Assistant 䊐 Other Healthcare 䊐 Nurse Practitioner Professional 䊐 Other

Address 2:

Name:

Postal Code:

Institution:

Country:

Address 1:

Email Address:

City: State:

An online version of this activity is now available. If you wish to receive credit for this activity, please refer to the website: www.wileyblackwellcme.com. Alternatively, this page can be sent by fax to Blackwell Futura Media Services, at (781)-338-8325. If you do not receive your certificate within 30 days of submission, please contact David Kempe, Editorial Program Coordinator, at dkempe@ wiley.com.

3816

J Sex Med 2010;7:3815–3816